Re: ‘Case of the Month’ from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: 99mTc-sestamibi SPECT-CT to Differentiate Renal Cell Carcinoma from Benign Oncocytoma: The promise of value-oriented, cost-effective, shared decision-making for patients with localized renal masses: new imaging tools for a new diagnostic work-up
Re: ‘Case of the Month’ from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: 99mTc-sestamibi SPECT-CT to Differentiate Renal Cell Carcinoma from Benign Oncocytoma: The promise of value-oriented, cost-effective, shared decision-making for patients with localized renal masses: new imaging tools for a new diagnostic work-up / Campi R.; Pecoraro A.; Serni S.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - ELETTRONICO. - 82:(2022), pp. 443-444. [10.1016/j.eururo.2022.06.011]
Re: ‘Case of the Month’ from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: 99mTc-sestamibi SPECT-CT to Differentiate Renal Cell Carcinoma from Benign Oncocytoma: The promise of value-oriented, cost-effective, shared decision-making for patients with localized renal masses: new imaging tools for a new diagnostic work-up
Campi R.;Pecoraro A.;Serni S.
2022
Abstract
Re: ‘Case of the Month’ from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: 99mTc-sestamibi SPECT-CT to Differentiate Renal Cell Carcinoma from Benign Oncocytoma: The promise of value-oriented, cost-effective, shared decision-making for patients with localized renal masses: new imaging tools for a new diagnostic work-upI documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.